What boswellia is
Boswellia serrata is a tree that produces a fragrant resin, known for centuries as Indian frankincense. The supplement is an extract of that resin. Its active parts are boswellic acids, with a specific one called AKBA getting most of the research attention. You will see it sold for joints both on its own and inside blends.
How boswellia works
Boswellic acids act on an enzyme called 5-lipoxygenase, which sits early in a pathway the body uses to produce inflammatory signals. By easing that pathway, boswellia may calm the low-grade joint inflammation that drives stiffness and discomfort. This is a different route from common over-the-counter pain medicine.
What the human research shows
The clinical signal here is fairly consistent. A systematic review of randomised trials in people with knee joint wear found that boswellia eased pain and stiffness and improved function better than placebo, with benefits showing up after about four weeks of use. Some trials even compared well against standard options.
The main caveats are trial size and product quality. Many studies are small, and independent testing shows the content of active boswellic acids varies enormously between products. We grade the evidence as moderate, which is strong for a herbal joint ingredient. Choosing a properly standardised extract is the key to getting what the trials tested.
What we still do not know
- The best standardised dose and the ideal boswellic acid content.
- How long the benefit lasts with continued use.
- How it compares directly with common joint medicines over the long term.
How people take boswellia
Most joint trials use a standardised extract at 100 mg to 250 mg per day, taken for at least a month before judging it. Because potency is so variable, the label should state the standardisation, ideally the AKBA or total boswellic acid content. If you take blood thinners or anti-inflammatory medicine, check with your healthcare provider first.